Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

SA health regulator registers J&J’s COVID-19 vaccine

SOUTH Africa’s health regulator has registered Johnson & Johnson’s  COVID-19 vaccine, paving the way for deliveries to start in the second quarter.

The registration of J&J’s vaccine is a boost for the country worst affected by the pandemic on the continent in terms of recorded infections and deaths. South Africa is counting on J&J to supply 31 million doses of its vaccine.

J&J said in a statement that the South African Health Products Regulatory Authority (SAHPRA) had “granted registration with conditions” for its single-dose vaccine.

SAHPRA’s spokesman confirmed that J&J’s vaccine had been registered when called by Reuters. He said more details would follow in a statement.


South Africa’s vaccination campaign was dealt a blow in early February when it put on hold a plan to start inoculations with AstraZeneca’s vaccine. A small research study showed AstraZeneca’s shot offered minimal protection against mild to moderate COVID-19 caused by the dominant local coronavirus variant.

The government switched to using the J&J shot in a research study to start protecting frontline healthcare workers. So far it has vaccinated roughly 260,000 people, out of 1.25 million healthworkers, according to health ministry data.

J&J aims to supply 2.8 million doses to South Africa in the second quarter, it said in its statement.

By The African Mirror